文献速递前列腺增生与排尿功能障碍男科与性医学

夜尿症与夜间多尿的管理

Management of Nocturia and Nocturnal Polyuria.
PubMed 文献 · Urology · 2019-10-02

夜间多尿指夜间尿量超过24小时总尿量的20%-33%(随年龄而异),是多数夜尿症的主要 contributing factor。夜尿症可由摄入、泌尿、肾脏、激素、睡眠及心血管因素引起,需通过排尿日记、问卷等明确类型及病因。生活方式调整为首选,症状进展时可药物治疗;去氨加压素是唯一专门用于夜间多尿所致夜尿症的抗利尿药。

要点

  • 夜间多尿定义为夜间尿量>24小时总尿量的20%-33%(随年龄而异)。
  • 诊断需结合排尿日记、问卷以区分夜间多尿、膀胱容量下降或全局多尿。
  • 去氨加压素是唯一专门用于夜间多尿所致夜尿症的抗利尿治疗。

核心结论

  • 夜间多尿病理生理复杂,需多学科方法有效诊断和管理。
  • 抗利尿治疗针对夜间多尿的根本原因,可显著减少夜间排尿次数。

主要发现

  • 夜间多尿是多数夜尿症病例的主要 contributing factor。
  • 夜尿症可由摄入、泌尿、肾脏、激素、睡眠及心血管因素引起。
  • 良性前列腺增生和膀胱过度活动症药物虽显著减少夜间排尿次数,但患者常未达临床有意义反应。
  • 去氨加压素是唯一专门用于夜间多尿所致夜尿症的抗利尿治疗。

关键数值与推荐

  • 夜间多尿定义为夜间尿量>24小时总尿量的20%-33%(随年龄而异)。
  • 去氨加压素是精氨酸加压素的合成类似物,为唯一专门用于夜间多尿所致夜尿症的抗利尿治疗。

临床怎么用

  • 通过详细病史、体格检查、排尿日记分析和问卷诊断夜尿症类型及病因。
  • 生活方式调整作为夜尿症和夜间多尿的首选干预。
  • 症状进展时启动药物治疗;夜间多尿所致夜尿症可使用去氨加压素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nocturnal polyuria (NP), characterized by overproduction of urine at night (greater than 20%-33% of total 24-hour urine volume depending on age), is a major contributing factor in most nocturia cases. Nocturia can be caused by intake, urological, nephrological, hormonal, sleep, and cardiovascular factors. It is therefore important to accurately diagnose both the type of nocturia and the potentially associated medical conditions to determine appropriate treatment. Diagnostic tools, in addition to a thorough history and physical examination, include voiding/bladder diary analyses and questionnaires to diagnose nocturia type (NP, diminished nocturnal/global bladder capacity, global polyuria) and causative factors. Lifestyle modifications are the first intervention implemented for the management of nocturia and NP but, as symptoms progress, such measures may be insufficient, and pharmacotherapy may be initiated. While drugs for benign prostatic hyperplasia and overactive bladder have demonstrated statistically significant reductions in nocturnal voids, patients often fail to achieve a clinically meaningful response. Antidiuretic treatment is warranted for patients with nocturia due to NP because, in many patients, it treats the underlying cause (ie, insufficient secretion of antidiuretic hormone arginine vasopressin) that leads to overproduction of urine at night and has been shown to provide statistically significant reductions in nocturnal voids. Desmopressin, a synthetic analog of arginine vasopressin, is the only antidiuretic treatment indicated specifically for nocturia due to NP. Overall, the pathophysiology of NP is complex and differs from that of other types of nocturia. A multidisciplinary approach is necessary to effectively diagnose and manage this bothersome condition.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Weiss JP, Everaert K. Management of Nocturia and Nocturnal Polyuria. Urology. 2019. PMID: 31586470. doi:10.1016/j.urology.2019.09.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。